CD14 and breast carcinoma: The percentages of macrophage-like cells in the peripheral blood, either in the PM-2 K+CD14+ (p = 0.0083; Fig. 1a) or the PM-2 K+CD14− subset (p < 0.0001; Fig. 1b), were significantly higher in patients with breast cancer than in healthy controls.